Candidiasis, Vulvovaginal: all 109 studies

Page 1 of 2. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.

• Photobiomodulation for Vaginal Dysfunctions: Home-Based vs Outpatient TreatmentNot yet recruitingNCT07697768Not applicable
• Evaluation of the Efficacy of a Probiotic Product as an Adjuvant Treatment for Vulvovaginal CandidiasisRecruitingNCT07603895Not applicable
• Biweekly Long-term Occidiofungin Study for Suppression of Mycotic RecurrenceRecruitingNCT07521137Phase 2
• Multi-Gyn FemiTotal for the Treatment and Prevention of Vulvovaginal Candidiasis Symptoms and Bacterial VaginosisRecruitingNCT07234786Not applicable
• Oteseconazole in the Treatment of Adults With Vulvovaginal Candidiasis（VVC）Not yet recruitingNCT07044947
• Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)RecruitingNCT06983041Not applicable
• Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/VulvovaginitisRecruitingNCT06835361Phase 2/3
• Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal CandidiasisRecruitingNCT06480604Not applicable
• Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal InfectionNot yet recruitingNCT06450990Phase 1/2
• Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant OutcomesRecruitingNCT05908682
• Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal MicrobiomeRecruitingNCT05753813Early Phase 1
• The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility StudyRecruitingNCT05434104Not applicable
• The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis SymptomsRecruitingNCT05367089Phase 3
• Use of 405nm Blue Light Emitting Diode in the Treatment of Women With Vulvovaginal Candidiasis: a Clinical TrialRecruitingNCT03075046Not applicable
• Pharmacokinetic Study in Healthy Lactating Women Exposed to IbrexafungerpCompletedNCT06954493Phase 1Results posted
• Point of Care Diagnosis of Vaginal InfectionsCompletedNCT06438575Not applicableResults posted
• Clinical Performance of the Gedea Pessary in Adult Women With Vulvovaginal CandidiasisCompletedNCT05507333Not applicableResults posted
• Ibrexafungerp for the Treatment of Complicated Vulvovaginal CandidiasisCompletedNCT05399641Phase 3Results posted
• Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)CompletedNCT04029116Phase 3Results posted
• Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal CandidiasisCompletedNCT03987620Phase 3Results posted
• Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast InfectionsCompletedNCT03840616Phase 3Results posted
• Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal CandidiasisCompletedNCT03761628Not applicableResults posted
• Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303)CompletedNCT03734991Phase 3Results posted
• A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)CompletedNCT03562156Phase 3Results posted
• A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)CompletedNCT03561701Phase 3Results posted
• Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal CandidiasisCompletedNCT03253094Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal TreatmentCompletedNCT03059992Phase 3Results posted
• Women's Improvement of Sexual Health (WISH) Demonstration ProjectCompletedNCT03045809Results posted
• Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)CompletedNCT02971007Phase 2Results posted
• A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)CompletedNCT02267382Phase 2Results posted
• Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal CandidiasisCompletedNCT02180828Phase 4Results posted
• Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal CandidiasisCompletedNCT02180100Phase 4Results posted
• Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal CandidiasisCompletedNCT01926028Phase 1/2Results posted
• A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection)CompletedNCT01891331Phase 2Results posted
• The Study Of Fluconazole For Vulvovaginal CandidiasisCompletedNCT01806623Phase 3Results posted
• Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative WomenCompletedNCT01230814Phase 2Results posted
• Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) TreatmentCompletedNCT01144286Phase 2Results posted
• A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% FormulationsCompletedNCT01039584Not applicableResults posted
• Monthly Itraconazole Versus Classic Homeopathy for Treatment of Recurrent Vulvovaginal Candidiasis (RVVC)CompletedNCT00895453Not applicableResults posted
• Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal CandidiasisCompletedNCT00803738Not applicableResults posted
• Oral Lactobacillus Crispatus Lc-G22 as Adjunctive Therapy for Vulvovaginal CandidiasisCompletedNCT07727967Not applicable
• An Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Vulvovaginal Candidiasis Compared With an Untreated Control GroupActive, not recruitingNCT07405853Not applicable
• Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal CandidiasisCompletedNCT07109869Phase 3
• Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida VaginitisCompletedNCT06975436
• Non-ablative Er:YAG for Recurrent CandidiasisCompletedNCT06572488Not applicable
• Safety and Tolerability Studies of CanProFem-AK, Vaginal Suppositories in Healthy VolunteersCompletedNCT06535126Phase 1
• Postbiotic as Adjunct Treatment for Vaginal CandidiasisCompletedNCT06474247Phase 2/3
• Efficacy and Safety of Natamycin and Lactulose Vaginal Suppositories in Treatment of Vulvovaginal CandidiasisCompletedNCT06411314Phase 3
• DeVEnIR: Defining Vulvovaginal Candidiasis - Elements of Infection and RemedyActive, not recruitingNCT06397248
• Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled StudyActive, not recruitingNCT06190509Phase 1/2
• Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South AfricaCompletedNCT06131749
• Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL OvuleCompletedNCT06056947Phase 3
• Genital Hygiene Training Provided to Turkish WomenCompletedNCT05998668Not applicable
• Zinc-containing Vaginal Gel and Oral Fluconazole for Vulvovaginal Candidiasis.CompletedNCT05895162Not applicable
• Lacticaseibacillus Rhamnosus CA15 (DSM 33960) Strain as a New Driver in Restoring the Normal Vaginal MicrobiotaCompletedNCT05796921Not applicable
• Blue Light Emitting Diode Therapy on Vulvovaginal CandidiasisCompletedNCT05795491Not applicable
• Sjögren and Gynecologic ConsiderationsCompletedNCT05670535
• Multi-Gyn FloraFem Study for Treatment of Vulvo Vaginal Candidiasis SymptomsCompletedNCT05552378Not applicable
• VVC Sampling Study for Analysis ValidationCompletedNCT05327192
• Effect of Ultra-gyn® on Vulvovaginal CandidiasisStatus unknownNCT05273333Not applicable
• Implementation of a Minor Ailment Service in Community Pharmacy PracticeCompletedNCT05247333Not applicable
• Comparative Performance of a Vaginal Yeast TestActive, not recruitingNCT05079711
• A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal CandidiasisStatus unknownNCT05074602Phase 3
• A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal CandidiasisStatus unknownNCT05059145Phase 2
• Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis.WithdrawnNCT05031481Phase 2
• Evaluation of VagiVitalAC for Treatment of Candida VulvovaginitisStatus unknownNCT05012852Not applicable
• A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Acute Vulvovaginal CandidiasisStatus unknownNCT04956419Phase 3
• Vulvovaginal Candidiasis in Canadian FemalesActive, not recruitingNCT04930107Early Phase 1
• Study Evaluating the Efficacy and Safety of Miconazole Nitrate + Domiphen Bromide Vaginal Cream in the Treatment of Subjects With Acute Vulvovaginal CandidiasisStatus unknownNCT04813822Phase 2
• A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)Status unknownNCT04734405Phase 2/3
• Study of Lactobacillus in Adjuvant Treatment of RVVCCompletedNCT04699240Phase 4
• Effect of a Lactobacillus Strain on the Prevention of Recurrent Vaginal CandidiasisStatus unknownNCT04639544Not applicable
• Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal CandidiasisStatus unknownNCT04626258Phase 4
• A Protocol for the Role of Fractional CO2 Laser in Consolidation Treatment of Recurrent Vulvovaginal CandidiasisStatus unknownNCT04292704Not applicable
• Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis ConditionsCompletedNCT04219605
• Comparison of Boric Acid vs. Terconazole in Treatment of RVVCStatus unknownNCT04208555Not applicable
• Study of the Vaginal Microbiota and the Potential of a Vaginal Probiotic Cream in Vaginal CandidosisCompletedNCT03975569Not applicable
• Evaluation of Efficacy and Safety of Gynomax® XL OvuleCompletedNCT03839875Phase 4
• Study on the Safety of the Approved Product Empedic L Cream During Its Routine Use (Active Ingredient is Clotrimazole 1%)CompletedNCT03599323
• Ketoconazole Gel Versus Terconazole Cream for Vaginal CandidiasisStatus unknownNCT03473418Phase 3
• Probiotic Implementation as Help in Solving Vaginal InfectionsCompletedNCT03372395Phase 2
• Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal CandidiasisWithdrawnNCT03167957Phase 2
• ProF-001_Phase IIaCompletedNCT03115073Phase 2/3
• Patients With Vulvovaginal CandidiasisStatus unknownNCT03024502Phase 1/2
• Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal CandidiasisWithdrawnNCT02907307Phase 3
• Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida ColonizationCompletedNCT02888197
• TOL-463 Phase 2 Study for VaginitisCompletedNCT02866227Phase 2
• Effect of Saccharomyces Cerevisiae on Vulvo-vaginal CandidiasisTerminatedNCT02859493Not applicable
• RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast InfectionsCompletedNCT02733432Phase 2
• Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora ColonisationCompletedNCT02730494Phase 1
• Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal CandidiasisCompletedNCT02679456Phase 2
• Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal CandidiasisCompletedNCT02251093Phase 3
• Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal CandidiasisCompletedNCT02248506Phase 4
• Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal CandidiasisCompletedNCT02242695Phase 4
• Comparing NAAT Testing to Standard Methods for the Diagnosis of VaginitisCompletedNCT02203942
• Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan WomenCompletedNCT02150655Early Phase 1
• Study of Antibiotic-induced Vaginal Yeast Infections in Healthy WomenTerminatedNCT01915251
• Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463CompletedNCT01812889Phase 1
• MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal CandidiasisCompletedNCT01497223Phase 2
• Observational Program Neo-Penotran® ForteCompletedNCT01335373

← Candidiasis, Vulvovaginal overview